Funded by
the European Union
On World Humanitarian Day, we recognise everyone who steps forward to support others during times of crisis. The COVID-19 pandemic reminded us that protecting public health is a collective effort. Healthcare professionals, researchers, volunteers and local communities all played a vital role in responding to an unprecedented global challenge. At EuCARE, we believe that collaboration, […]
World Humanitarian Day Read More »
Research from the EuCARE POST COVID Study has been accepted for a poster presentation at the 4th Long COVID International Conference 2026 taking place in November. Presented by Prof. Camilla Tincati, the study “Severe Acute COVID-19 Is Associated With Depressive Symptoms and Reduced Anxiety Resolution During Post-Acute Follow-Up” explores the relationship between the severity of
Another EuCARE study is heading to an international stage! Read More »
The EuCARE Final Conference is taking place on 1–2 October 2026 in Rome, Italy. Over two days, researchers, healthcare professionals, policymakers and project partners will come together to reflect on the knowledge generated throughout the EuCARE project and discuss how it can help strengthen pandemic preparedness for the future. Join us as we share key
The EuCARE Final Conference is coming soon Read More »
Summer is a time to slow down, reflect and recharge. At EuCARE, we remain committed to advancing research, fostering collaboration and strengthening pandemic preparedness – while embracing the slower pace of the season. Thank you for following our journey. We wish you a restful summer and look forward to sharing more updates with you after
EuCARE wishes a happy summer break Read More »
At EuCARE, we investigate how evolutionary changes in the virus can lead to the lack of detection of potentially serious SARS-CoV-2 outbreaks, for example due to atypical symptoms upon presentation or failure of diagnostic test. This Ebola Bundibugyo outbreak is teaching us again that, no matter how prepared we think we are, a new zoonotic
Every outbreak is different, but every outbreak teaches us something Read More »
Long COVID continues to affect the lives of many people, including healthcare workers who were on the front line of the COVID-19 pandemic. 🔬 As part of the WHO Healthcare Workers project, EuCARE is contributing to an international study exploring both the burden of Long COVID among healthcare workers and their knowledge, attitudes and practices
Recently, EuCARE research was featured at EBMLive 2026 in Oxford through two oral presentations showcasing studies developed within the consortium. Giulia Doi presented a meta-analysis on the prevalence of anxiety, depression and distress among cancer patients during the COVID-19 pandemic. The study was selected for the conference’s Plenary Session under the Enhancing Evidence for Public
EuCARE research was featured at EBMLive 2026 in Oxford Read More »
Another successful edition of the European Meeting on HIV & Hepatitis (Barcelona, Spain) has come to an end. As an EMHH 2026 Endorser, EuCARE was proud to support a meeting that continues to bring together researchers, clinicians and healthcare professionals to discuss the latest developments in infectious diseases and antiviral research. The event also provided
As a Endorser, EuCARE was proud to support the European Meeting on HIV & Hepatitis 2026 Read More »
🦠 SARS-CoV-2 and Ebola virus are both zoonotic pathogens, but they differ significantly in how they spread, the disease they cause and their public health impact. While SARS-CoV-2 led to a global pandemic due to its highly efficient human-to-human transmission, Ebola outbreaks are typically more localized. Understanding the rationale for these differences is essential for
Understanding the rationale for these differences is essential Read More »
The 24th European Meeting on HIV & Hepatitis (EMHH 2026) will take place in Barcelona, Spain, from 10–12 June 2026. Bringing together clinicians, researchers and healthcare professionals, EMHH provides a platform to discuss the latest developments in HIV and hepatitis research, antiviral therapies and clinical practice. EuCARE will be there, contributing to the exchange of